Cost-effectiveness analysis of ipilimumab in previously untreated patients with unresectable malignant melanoma in scotland

Publication Type:
Poster


Citation:

Lee D, Porter J, Hatswell AJ, Hertel N and Walker A. Cost-effectiveness analysis of ipilimumab in previously untreated patients with unresectable malignant melanoma in scotland. 17th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Amsterdam, The Netherlands. 8-12 November 2014. Poster PRM37.

 


Link to publication ⟶

⟵ Back to Search Results